Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis B Harrison

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Neoplasia (New York, N.Y.)|October 7, 2021
Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurabilityJuan C L Alfonso, G Daniel Grass, Eric Welsh, et al.
Cancer|November 14, 2015
Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancerJessica M Frakes, Arash O Naghavi, Stephanie K Demetriou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2022
The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation TherapyG Daniel Grass, Juan C L Alfonso, Eric Welsh, et al.
Anticancer Research|October 15, 2013
Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumesWaleed F Mourad, Daniel Shasha, Dukagjin M Blakaj, et al.
Journal of Medical Imaging and Radiation Oncology|December 1, 2020
Pretreatment CT and <sup>18</sup> F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancerAnupam Rishi, Geoffrey G Zhang, Zhigang Yuan, et al.
Annals of Surgical Oncology|October 13, 2018
Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?Matthew C Perez, Daniel E Oliver, Evan S Weitman, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 5, 2021
Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapyZhigang Yuan, Marissa Frazer, Anupam Rishi, et al.
Journal of Neuro-Oncology|May 4, 2017
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastasesKamran A Ahmed, Sungjune Kim, John Arrington, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Journal of the American College of Cardiology|June 27, 2002
Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric studyAkiko Maehara, Neil S Patel, Louis B Harrison, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Neoplasia (New York, N.Y.)|October 7, 2021
Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurabilityJuan C L Alfonso, G Daniel Grass, Eric Welsh, et al.
Cancer|November 14, 2015
Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancerJessica M Frakes, Arash O Naghavi, Stephanie K Demetriou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2022
The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation TherapyG Daniel Grass, Juan C L Alfonso, Eric Welsh, et al.
Anticancer Research|October 15, 2013
Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumesWaleed F Mourad, Daniel Shasha, Dukagjin M Blakaj, et al.
Journal of Medical Imaging and Radiation Oncology|December 1, 2020
Pretreatment CT and <sup>18</sup> F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancerAnupam Rishi, Geoffrey G Zhang, Zhigang Yuan, et al.
Annals of Surgical Oncology|October 13, 2018
Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?Matthew C Perez, Daniel E Oliver, Evan S Weitman, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 5, 2021
Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapyZhigang Yuan, Marissa Frazer, Anupam Rishi, et al.
Journal of Neuro-Oncology|May 4, 2017
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastasesKamran A Ahmed, Sungjune Kim, John Arrington, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Journal of the American College of Cardiology|June 27, 2002
Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric studyAkiko Maehara, Neil S Patel, Louis B Harrison, et al.
Pageof 13